Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Aishwarya Jala, Srikanth Ponneganti, Devi Swetha Vishnubhatla, Gayathri Bhuvanam, Prithvi Raju Mekala, Bincy Varghese, Pullapanthula Radhakrishnanand, Ramu Adela, Upadhyayula Suryanarayana Murty & Roshan M. Borkar. (2021) Transporter-mediated drug–drug interactions: advancement in models, analytical tools, and regulatory perspective. Drug Metabolism Reviews 53:3, pages 285-320.
Read now
Read now
Joseph Berthier, Mehdi Benmameri, François-Ludovic Sauvage, Gabin Fabre, Benjamin Chantemargue, Hélène Arnion, Pierre Marquet, Patrick Trouillas, Nicolas Picard & Franck Saint-Marcoux. (2021) MRP4 is responsible for the efflux transport of mycophenolic acid β-d glucuronide (MPAG) from hepatocytes to blood. Xenobiotica 51:1, pages 105-114.
Read now
Read now
Articles from other publishers (30)
Lin Cheng, Pu Yao, Bangbi Weng, Ming Yang & Qian Wang. (2022) Meta-analysis of the associations of IMPDH and UGT1A9 polymorphisms with rejection in kidney transplant recipients taking mycophenolic acid. European Journal of Clinical Pharmacology 78:8, pages 1227-1238.
Crossref
Crossref
Nicoló Milani, Neil Parrott, Daniela Ortiz Franyuti, Patricio Godoy, Aleksandra Galetin, Michael Gertz & Stephen Fowler. (2022)
Application of a gut–liver-on-a-chip device and mechanistic modelling to the quantitative
in vitro
pharmacokinetic study of mycophenolate mofetil
. Lab on a Chip 22:15, pages 2853-2868.
Crossref
Crossref
Ryota Tanaka, Asami Matsumoto, Ryosuke Tatsuta, Tadasuke Ando, Toshitaka Shin, Hiromitsu Mimata & Hiroki Itoh. (2022) Sustained suppression of enterohepatic circulation of mycophenolic acid by antimicrobial‐associated diarrhea in a kidney transplant recipient with Crohn's disease: A case report. Clinical Case Reports 10:6.
Crossref
Crossref
Takahito Endo, Takeshi Ishimura, Shun Nishioka, Naoki Yokoyama, Satoshi Ogawa & Masato Fujisawa. (2022) No Influence of Everolimus on Mycophenolic Acid Area Under the Concentration–Time Curve: Limited Sampling Strategy for Mycophenolic Acid in Japanese Kidney Transplant Recipients Treated With Tacrolimus, Mycophenolate Mofetil, Steroid, and Everolimus. Transplantation Proceedings 54:2, pages 286-292.
Crossref
Crossref
Erkka Järvinen, Feng Deng, Wilma Kiander, Alli Sinokki, Heidi Kidron & Noora Sjöstedt. (2022) The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates. Frontiers in Pharmacology 12.
Crossref
Crossref
Daniel Brazeau, Calvin J. Meaney, Joseph D. Consiglio, Gregory E. Wilding, Louise M. Cooper, Rocco C. Venuto & Kathleen M. Tornatore. (2021)
Association of
ABCC2
Haplotypes to Mycophenolic Acid Pharmacokinetics in Stable Kidney Transplant Recipients
. The Journal of Clinical Pharmacology 61:12, pages 1592-1605.
Crossref
Crossref
V. Sashi Gopaul, Anna Vildhede, Tommy B. Andersson, Fredrik Erlandsson, Caroline A. Lee, Susanne Johansson & Constanze Hilgendorf. (2021) In Vitro Assessment of the Drug–Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters. Journal of Pharmacology and Experimental Therapeutics 378:2, pages 108-123.
Crossref
Crossref
Jin Zhou, Upendra A. Argikar & John O. Miners. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
301
338
.
Quentin Faucher, Hugo Alarcan, Pierre Marquet & Chantal Barin-Le Guellec. (2020) Effects of Ischemia-Reperfusion on Tubular Cell Membrane Transporters and Consequences in Kidney Transplantation. Journal of Clinical Medicine 9:8, pages 2610.
Crossref
Crossref
Juthipong Benjanuwattra, Dumnoensun Pruksakorn & Nut Koonrungsesomboon. (2019) Mycophenolic Acid and Its Pharmacokinetic Drug‐Drug Interactions in Humans: Review of the Evidence and Clinical Implications. The Journal of Clinical Pharmacology 60:3, pages 295-311.
Crossref
Crossref
Mo'tasem M. Alsmadi, Mahdi Qasem Alfarah, Jawaher Albderat, Ghazi Alsalaita, Reham AlMardini, Salim Hamadi, Ahmad Al‐Ghazawi, Omar Abu‐Duhair & Nasir Idkaidek. (2019) The development of a population physiologically based pharmacokinetic model for mycophenolic mofetil and mycophenolic acid in humans using data from plasma, saliva, and kidney tissue. Biopharmaceutics & Drug Disposition 40:9, pages 325-340.
Crossref
Crossref
Calvin J. Meaney, Patcharaporn Sudchada, Joseph D. Consiglio, Gregory E. Wilding, Louise M. Cooper, Rocco C. Venuto & Kathleen M. Tornatore. (2019) Influence of Calcineurin Inhibitor and Sex on Mycophenolic Acid Pharmacokinetics and Adverse Effects Post–Renal Transplant. The Journal of Clinical Pharmacology 59:10, pages 1351-1365.
Crossref
Crossref
Ana Spasić, Aleksandra Catić-Đorđević, Radmila Veličković-Radovanović, Nikola Stefanović, Predrag Džodić & Tatjana Cvetković. (2019) Adverse effects of mycophenolic acid in renal transplant recipients: gender differences. International Journal of Clinical Pharmacy 41:3, pages 776-784.
Crossref
Crossref
Izna Ali, Jason R. Slizgi, Josh D. Kaullen, Marija Ivanovic, Mikko Niemi, Paul W. Stewart, Alfred S. BarrittIVIV & Kim L.R. Brouwer. (2018) Transporter-Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate. Clinical Pharmacology & Therapeutics 104:4, pages 749-756.
Crossref
Crossref
Kazuaki Yoshimura, Ikuko Yano, Takashi Yamamoto, Tadakazu Kondo, Misaki Kawanishi, Yui Isomoto, Atsushi Yonezawa, Akifumi Takaori-Kondo & Kazuo Matsubara. (2018) Pharmacokinetic and Pharmacodynamic Markers of Mycophenolic Acid Associated with Effective Prophylaxis for Acute Graft-Versus-Host Disease and Neutrophil Engraftment in Cord Blood Transplant Patients. Biology of Blood and Marrow Transplantation 24:7, pages 1441-1448.
Crossref
Crossref
K Yoshimura, I Yano, T Yamamoto, M Kawanishi, Y Isomoto, A Yonezawa, T Kondo, A Takaori-Kondo & K Matsubara. (2017) Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplantation 53:1, pages 44-51.
Crossref
Crossref
Anton Ivanyuk, Françoise Livio, Jérôme Biollaz & Thierry Buclin. (2017) Renal Drug Transporters and Drug Interactions. Clinical Pharmacokinetics 56:8, pages 825-892.
Crossref
Crossref
Jeremiah D. Momper, Michael L. Misel & Dianne B. McKay. (2017) Sex differences in transplantation. Transplantation Reviews 31:3, pages 145-150.
Crossref
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
77
138
.
Ana C. Alvarez-Elías, Elisa C. Yoo, Ekaterina K. Todorova, Ram N. Singh & Guido Filler. (2017) A Retrospective Study on Mycophenolic Acid Drug Interactions: Effect of Prednisone, Sirolimus, and Tacrolimus With MPA. Therapeutic Drug Monitoring 39:3, pages 220-228.
Crossref
Crossref
Shufan Ge, Yifan Tu & Ming Hu. (2016) Challenges and Opportunities with Predicting In Vivo Phase II Metabolism via Glucuronidation From In Vitro Data. Current Pharmacology Reports 2:6, pages 326-338.
Crossref
Crossref
Mi Hye Kwon, Ji Na Yoon, Yu Jin Baek, Yu Chul Kim, Yong Yeon Cho & Hee Eun Kang. (2016) Effects of poloxamer 407-induced hyperlipidemia on hepatic multidrug resistance protein 2 (Mrp2/Abcc2) and the pharmacokinetics of mycophenolic acid in rats. Biopharmaceutics & Drug Disposition 37:6, pages 352-365.
Crossref
Crossref
Lisa C. Martial, Bart A. W. Jacobs, Elisabeth A. M. Cornelissen, Anton F. J. de Haan, Birgit C. P. Koch, David M. Burger, Rob E. Aarnoutse, Michiel F. Schreuder & Roger J.M. Br?ggemann. (2016) Pharmacokinetics and target attainment of mycophenolate in pediatric renal transplant patients. Pediatric Transplantation 20:4, pages 492-499.
Crossref
Crossref
Heike Bittersohl & Werner Steimer. 2016. Personalized Immunosuppression in Transplantation. Personalized Immunosuppression in Transplantation
199
226
.
Vladimir Trkulja, Zdenka Lalić, Sandra Nađ-Škegro, Ana Lebo, Paula Granić, Mila Lovrić, Josip Pasini & Nada Božina. (2014) Effect of Cyclosporine on Steady-State Pharmacokinetics of MPA in Renal Transplant Recipients Is Not Affected by the MPA Formulation. Therapeutic Drug Monitoring 36:4, pages 456-464.
Crossref
Crossref
Azza A.K. El-Sheikh, Jan B. Koenderink, Alfons C. Wouterse, Petra H.H. van den Broek, Vivienne G.M. Verweij, Rosalinde Masereeuw & Frans G.M. Russel. (2014) Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus. Translational Research 164:1, pages 46-56.
Crossref
Crossref
Christine E. Staatz & Susan E. Tett. (2014) Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Archives of Toxicology 88:7, pages 1351-1389.
Crossref
Crossref
Jean-Baptiste Woillard, Nicolas Picard, Antoine Thierry, Guy Touchard & Pierre Marquet. (2014) Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients. Pharmacogenetics and Genomics 24:5, pages 256-262.
Crossref
Crossref
Maciej J. Zamek-Gliszczynski, Xiaoyan Chu, Joseph W. Polli, Mary F. Paine & Aleksandra Galetin. (2014) Understanding the Transport Properties of Metabolites: Case Studies and Considerations for Drug Development. Drug Metabolism and Disposition 42:4, pages 650-664.
Crossref
Crossref
Norikazu Matsunaga, Sho Wada, Takeo Nakanishi, Miho Ikenaga, Mikio Ogawa & Ikumi Tamai. (2013)
Mathematical Modeling of the
in Vitro
Hepatic Disposition of Mycophenolic Acid and Its Glucuronide in Sandwich-Cultured Human Hepatocytes
. Molecular Pharmaceutics 11:2, pages 568-579.
Crossref
Crossref